Elevance Beats Expectations, Boosts Forecast on Cost Control.

The article focuses on Elevance Health Inc.'s first-quarter financial performance, highlighting that the company exceeded Wall Street expectations and raised its full-year profit guidance due to improved management of medical costs. Despite challenges such as high Medicaid costs, lower-than-expected profit margins in its Carelon health services unit, and ongoing pressure from U.S. government policy changes—including reduced Medicaid funding and potential sanctions related to Medicare Advantage plans—Elevance's large commercial insurance business provides some insulation. The company’s results, alongside those of UnitedHealth Group Inc., suggest cautious optimism for the health insurance industry amid efforts to control government health program payments. [Extracted from the article]